Spyre Therapeutics, Inc. (SYRE)
74.00
+1.00
(+1.37%)
USD |
NASDAQ |
May 07, 10:41
Spyre Therapeutics Free Cash Flow : -185.87M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tyra Biosciences, Inc. | -95.28M |
| Replimune Group, Inc. | -283.27M |
| Savara, Inc. | -101.06M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Agios Pharmaceuticals, Inc. | -384.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -57.54M |
| Cash from Investing (Quarterly) | 56.58M |
| Cash from Financing (Quarterly) | 12.43M |
| Free Cash Flow Per Share (Quarterly) | -0.7326 |
| Free Cash Flow to Equity (Quarterly) | -57.54M |
| Free Cash Flow to Firm (Quarterly) | -57.54M |
| Free Cash Flow Yield | -3.65% |